Number of Shares Subject to Warrant. Subject to the terms and conditions hereinafter set forth, the Holder is entitled, upon surrender of this Warrant at the principal office of the Company, to purchase from the Company, at a price equal to the Exercise Price (as defined in Section 2 below), shares of the Warrant Stock. For purposes of this Warrant:
Number of Shares Subject to Warrant. The number of shares subject to this Warrant will be calculated as follows:
Number of Shares Subject to Warrant. (a) This is to certify that, FOR VALUE RECEIVED, Battery Ventures VII, L.P. (the “Investor”), is entitled, subject to the terms set forth below, to purchase from the Company, upon surrender of this Warrant, at any time or times on or after the date hereof, but prior to the termination of this Warrant pursuant to Section 3 hereof, at the Warrant Price, 1,090,222 shares (the “Warrant Shares”) of the Company’s common stock, $0.001 par value per share (“Common Stock”), upon such Investor’s exercise of this Warrant pursuant to Section 7 hereof. Certain capitalized terms used in this Warrant are defined in Section 2 hereof.
Number of Shares Subject to Warrant. FOR VALUE RECEIVED, on and after the Commencement Date (as defined below), and subject to the terms and conditions herein set forth, the Holder (as defined below) is entitled to purchase from Telocity, Inc., a California corporation (the "Company"), at any time before 5:00 p.m. California time on December 13, 2004 ("Termination Date"), at a price per share equal to the Warrant Price (as defined below), the Warrant Stock (as defined below and subject to adjustments as described below) upon exercise of this Warrant pursuant to Section 6 hereof.
Number of Shares Subject to Warrant. Subject to the terms and conditions hereinafter set forth, the Holder is entitled, upon surrender of this Warrant at the principal office of the Company, to purchase from the Company, at a price equal to $1.25 per share (the “Exercise Price”), 249,160 shares of Common Stock of the Company (the “Shares”). The Exercise Price and the number of Shares subject to purchase under this Warrant each is subject to adjustment as set forth in Section 5.
Number of Shares Subject to Warrant. FOR VALUE RECEIVED, subject to the terms and conditions herein set forth, Aston Capital Partners L.P. (the "HOLDER") is entitled to purchase from Viisage Technology, Inc., a Delaware corporation (the "COMPANY"), up to Three Hundred and Twenty Thousand (320,000) shares (the "WARRANT SHARES") of the Company's common stock, par value 0.001 per share (the "COMMON STOCK"), at a price per share equal to Thirteen Dollars and Seventy-Five Cents ($13.75) per share (the "WARRANT Price"), upon exercise of this Common Stock Purchase Warrant (the "WARRANT") pursuant to the provisions set forth herein. This Warrant is issued pursuant to that certain Investment Agreement dated as of October 5, 2005 between the Company L-1 Investment Partners LLC (which assigned its rights and obligations thereunder to the Holder) (the "INVESTMENT AGREEMENT"). The Holder is subject to certain restrictions and entitled to certain rights as set forth in the Investment Agreement and that certain Registration Rights Agreement of even date herewith by and among the Company and the Holder (the "REGISTRATION RIGHTS AGREEMENT").
Number of Shares Subject to Warrant. (a) This is to certify that, FOR VALUE RECEIVED, Printworks Series E LLC (the “Investor”), is entitled, subject to the terms set forth below, to purchase from the Company, upon surrender of this Warrant, at any time or times on or after the date hereof, but prior to the termination of this Warrant pursuant to Section 3 hereof, at the Warrant Price, 1,111,111 shares (the “Warrant Shares”) of the Company’s common stock, $0.001 par value per share (“Common Stock”), upon such Investor’s exercise of this Warrant pursuant to Section 7 hereof. Certain capitalized terms used in this Warrant are defined in Section 2 hereof.
Number of Shares Subject to Warrant. ALIEN TECHNOLOGY CORPORATION (the “Company”), for value received, hereby certifies that AEI Holding Corporation, or its registered assigns (the “Registered Holder”), is entitled, subject to the terms set forth below, to purchase from the Company the amount and kind of shares of the Company, at a purchase price per share, subject to adjustment as hereinafter provided, upon the occurrence of certain events, all as provided below. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Stock” and the “Warrant Price,” respectively. This Warrant shall expire on the earliest of (i) 5:00 p.m., Pacific time, on July 31, 2010; (ii) the closing of the sale of the Company’s Common Stock pursuant to a registration statement filed by the Company under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the first underwritten offering of its securities to the general public (the “IPO”); or (iii) the effective date of a Change of Control (the “Termination Date”).
Number of Shares Subject to Warrant. Subject to the terms and conditions herein set forth, Liminal BioSciences Inc. (the “Warrantholder”) is entitled to purchase from Ocugen, Inc. (the “Company”), a Delaware corporation, an aggregate of [____] fully paid and non-assessable shares (which number of shares is subject to adjustment as described below) (the “Shares”) of the Company’s Common Stock, $0.01 par value per share (the “Common Stock”), upon surrender of this Warrant to the Company prior to the Expiration Date (as defined below) and upon payment of the Purchase Price (as defined below). This Warrant is being issued to the Warrantholder as consideration for and pursuant to that certain Letter of Intent to Purchase Commercial Real Estate (“LOI”), dated as of January 24, 2022, by and between the Company and the Warrantholder. All capitalized terms used herein but not otherwise defined shall have the meanings assigned to such terms in the LOI (which meanings shall survive the termination of the LOI).
Number of Shares Subject to Warrant. Subject to the terms and conditions herein set forth, (the “Warrantholder”) is entitled to purchase from Ocugen, Inc. (the “Company”), a Delaware corporation, an aggregate of [___] fully paid and non-assessable shares (which number of shares is subject to adjustment as described below) (the “Shares”) of the Company’s Common Stock, $0.001 par value per share(the “Common Stock”), upon surrender of this Warrant to the Company prior to the Expiration Date (as defined below) and upon payment of the Purchase Price (as defined below).
